IU plays significant role in FDA approval of new bladder cancer treatment
Nabil Adra, MD, is among the authors of results recently published in the prestigious New England Journal of Medicine from a multi-year clinical trial called KEYNOTE-905. With this new treatment regimen, a substantially higher percentage of patients with bladder cancer will be cured of their cancer.



